Vacunas infantiles Archives - CVEEP Skip to main content
Vacunas | Adultos mayores | Embarazo | Enfermedades respiratorias infecciosas | Inmunocomprometido | Vacunas infantiles | VRS

Beneficios de la inmunización para las poblaciones de alto riesgo

Los adultos mayores, los niños pequeños y las personas con ciertas afecciones de salud tienen un mayor riesgo de padecer enfermedades respiratorias graves.
Actualizado el 03/26/2025
Beneficios de la inmunización para las poblaciones de alto riesgo
Descarga el PDF
| COVID-19 | Guía | Influenza (gripe) | La enfermedad neumocócica | La tosferina (también llamada tos convulsa) | Vacunas | Vacunas infantiles | VRS

Infectious Respiratory Disease Immunization Timeline: Children and Adolescents (Ages 6-17)

Content on this page is being updated to reflect the FDA’s August 27 approval of the 2026–2027 COVID-19 vaccine formula. Please check back soon.

Immunization is the best protection against many infectious respiratory illnesses. Vaccines strengthen our immune defenses and reduce the severity and spread of disease.
Actualizado el 03/20/2025
Infectious Respiratory Disease Immunization Timeline: Children and Adolescents (Ages 6-17)
Descarga el PDF
| COVID-19 | Guía | Influenza (gripe) | La enfermedad neumocócica | La tosferina (también llamada tos convulsa) | Vacunas | Vacunas infantiles | VRS

Infectious Respiratory Disease Immunization Timeline: Babies and Young Children (Ages 2 Months-6 Years)

Content on this page is being updated to reflect the FDA’s August 27 approval of the 2026–2027 COVID-19 vaccine formula. Please check back soon.

Immunization is the best protection against many infectious respiratory illnesses. Vaccines strengthen our immune defenses and reduce the severity and spread of disease.
Actualizado el 03/20/2025
Infectious Respiratory Disease Immunization Timeline: Babies and Young Children (Ages 2 Months-6 Years)
Descarga el PDF
Vacunas | La enfermedad neumocócica | Vacunas infantiles

Lo que debes saber sobre las vacunas antineumocócicas para niños y adolescentes

La enfermedad neumocócica es peligrosa para los niños y adolescentes, y los menores de 5 años corren un riesgo especialmente alto. Vacunarse contra el neumococo ayuda a prevenir infecciones graves que pueden llevar a la hospitalización o incluso a la muerte.
Actualizado el 03/06/2025
Lo que debes saber sobre las vacunas antineumocócicas para niños y adolescentes
Descarga el PDF
Vacunas | Adultos mayores | COVID-19 | Enfermedades respiratorias infecciosas | Guía | Influenza (gripe) | La enfermedad neumocócica | La tosferina (también llamada tos convulsa) | Vacunas infantiles | VRS

Calendarios de Inmunización Contra Enfermedades Respiratorias Infecciosas

Actualizado el 10/07/2024
Calendarios de Inmunización Contra Enfermedades Respiratorias Infecciosas
Descarga el PDF
| COVID-19 | Guía | Vacunas | Vacunas infantiles

What to Know About Recommendations and Coverage for Updated COVID-19 Vaccines: Children (Ages 6 Months–4 Years)

Content on this page is being updated to reflect the FDA’s August 27 approval of the 2026–2027 COVID-19 vaccine formula. Please check back soon.

The latest COVID-19 vaccine is recommended for children between the ages of 6 months and 4 years. Children in this age group may need multiple doses of the vaccine to be considered “up to date.”
Actualizado el 09/20/2024
What to Know About Recommendations and Coverage for Updated COVID-19 Vaccines: Children (Ages 6 Months–4 Years)
Descarga el PDF

*NOTE: COVID-19 and RSV vaccine recommendations have recently been updated for some populations. This resource will be updated to reflect the CDC’s latest guidance. Because CDC recommendations may impact insurance coverage, you should check with your insurance provider to make sure you’re covered.

| COVID-19 | Guía | Vacunas | Vacunas infantiles

What to Know About Recommendations and Coverage for Updated COVID-19 Vaccines: Children, Teens, and Adults (Ages 5–64)

Content on this page is being updated to reflect the FDA’s August 27 approval of the 2026–2027 COVID-19 vaccine formula. Please check back soon.

The latest COVID-19 vaccine is recommended for people ages 5–64 years.
Actualizado el 09/03/2024
What to Know About Recommendations and Coverage for Updated COVID-19 Vaccines: Children, Teens, and Adults (Ages 5–64)
Descarga el PDF

*NOTE: COVID-19 and RSV vaccine recommendations have recently been updated for some populations. This resource will be updated to reflect the CDC’s latest guidance. Because CDC recommendations may impact insurance coverage, you should check with your insurance provider to make sure you’re covered.